Ǫ1FY27 – Sakar Healthcare Records 38% YoY Revenue Growth PAT Rises 120%
Ahmedabad (Gujarat) [India], July 27: Sakar Healthcare Ltd |NSE: SAKAR, with a research-driven API-integrated EU GMP approved oncology orals and injection manufacturing unit, has announced its unaudited financial results for the financial year ended 30th Jun 2026. Ǫ1FY27 Consolidated Financial Performance Particulars (INR Lakhs) Ǫ1FY27 Ǫ1FY26 Y-o-Y FY26 Revenue from Operations 7,2G7.25 5,273.62 38% 25,173.60 […]
Continue Reading